Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

PRQR

ProQR Therapeutics N.V

May 01 • 01:21PM ET

1.58

+0.00 0.32 %

Healthcare • Biotechnology • Netherlands • Micro • NASD

Peers: ALNY SRPT BMRN IONS ARWR QURE BBIO RGNX BLUE ADVM

| Held by: QQQS

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.45	Insider Own	32.21%	Shs Outstand	103.01M	Perf Week	1.61%
Market Cap	165.95M	Forward P/E	-	EPS next Y	-0.70	Insider Trans	0.00%	Shs Float	71.43M	Perf Month	-7.89%
Enterprise Value	73.85M	PEG	-	EPS next Q	-0.14	Inst Own	36.61%	Short Float	1.77%	Perf Quarter	-2.78%
Income	-47.66M	P/S	9.27	EPS this Y	-26.22%	Inst Trans	-0.42%	Short Ratio	2.39	Perf Half Y	-40.57%
Sales	17.91M	P/B	2.80	EPS next Y	-18.69%	ROA	-31.11%	Short Interest	1.26M	Perf YTD	-22.03%
Book/sh	0.56	P/C	1.53	EPS next 5Y	11.17%	ROE	-63.67%	52W High	3.10 -49.19%	Perf Year	-8.43%
Cash/sh	1.03	P/FCF	-	EPS past 3/5Y	21.80% 15.68%	ROIC	-68.87%	52W Low	1.33 18.42%	Perf 3Y	-30.31%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	68.13% -	Gross Margin	82.95%	Volatility	9.31% 9.50%	Perf 5Y	-74.68%
Dividend TTM	-	EV/Sales	4.12	EPS Y/Y TTM	-30.17%	Oper. Margin	-276.57%	ATR (14)	0.14	Perf 10Y	-71.52%
Dividend Ex-Date	-	Quick Ratio	3.09	Sales Y/Y TTM	-12.37%	Profit Margin	-266.13%	RSI (14)	44.02	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	3.09	EPS Q/Q	1.95%	SMA20	-10.13%	Beta	0.07	Target Price	9.04
Payout	-	Debt/Eq	0.28	Sales Q/Q	18.77%	SMA50	-6.10%	Rel Volume	0.74	Prev Close	1.57
Employees	-	LT Debt/Eq	0.19	Earnings	Mar 12 BMO	SMA200	-21.84%	Avg Volume	528.04K	Price	1.58
IPO	Sep 18, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	-0.58% -16.18%	Trades		Volume	240,141	Change	0.32%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)